YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

Bayer, Loxo to collaborate on cancer drugs

Posted online

Loxo Oncology Inc. and Bayer are collaborating to develop and commercialize two cancer drugs.

The deal could bring the U.S. drug developer up to $1.55 billion.

Loxo will receive a $400 million upfront payment, followed by incentive payments for milestones.

Read more from RTT News.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Fall 2026 Architects & Engineers Project Report

This installment of Springfield Business Journal’s Architects & Engineers Project Report showcases 26 endeavors by area design and engineering professionals.

Most Read
Update cookies preferences